title: Iron and lymphocytes: reciprocal regulatory interactions.
authors.affiliation: Abel Salazar Institute for the Biomedical Sciences, Oporto, Portugal.
authors.forename: M
authors.initials: M
authors.lastname: de Sousa
authors.forename: R
authors.initials: R
authors.lastname: Reimão
authors.forename: G
authors.initials: G
authors.lastname: Porto
authors.forename: R W
authors.initials: RW
authors.lastname: Grady
authors.forename: M W
authors.initials: MW
authors.lastname: Hilgartner
authors.forename: P
authors.initials: P
authors.lastname: Giardina
mesh_terms: D000818:Animals; D001815:Bloodletting; D016516:CD4-CD8 Ratio / Q000187:drug effects; D015913:Chelation Therapy; D003676:Deferoxamine / Q000494:pharmacology; D005290:Ferric Compounds / Q000633:toxicity; D006432:Hemochromatosis / Q000139:chemically induced / Q000235:genetics / Q000503:physiopathology* / Q000628:therapy; D007501:Iron / Q000502:physiology* / Q000633:toxicity; D051379:Mice; D008954:Models, Biological; D051381:Rats; D011919:Rats, Inbred Strains; D011920:Rats, Inbred WF; D016176:T-Lymphocyte Subsets / Q000187:drug effects / Q000502:physiology*; D013789:Thalassemia / Q000188:drug therapy / Q000503:physiopathology
chemical_list: D005290:Ferric Compounds; C025314:ferric citrate; D007501:Iron; D003676:Deferoxamine